380 related articles for article (PubMed ID: 14658972)
21. Mirtazapine versus fluoxetine in the treatment of panic disorder.
Ribeiro L; Busnello JV; Kauer-Sant'Anna M; Madruga M; Quevedo J; Busnello EA; Kapczinski F
Braz J Med Biol Res; 2001 Oct; 34(10):1303-7. PubMed ID: 11593305
[TBL] [Abstract][Full Text] [Related]
22. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
[TBL] [Abstract][Full Text] [Related]
23. Antidepressant treatment of the depressed patient with insomnia.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 17():28-31; discussion 46-8. PubMed ID: 10446739
[TBL] [Abstract][Full Text] [Related]
24. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
25. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
26. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
[TBL] [Abstract][Full Text] [Related]
27. Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder.
Wang D; Li Z; Li L; Hao W
Asia Pac Psychiatry; 2014 Jun; 6(2):152-60. PubMed ID: 23857869
[TBL] [Abstract][Full Text] [Related]
28. Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With Mirtazapine.
Funaki K; Nakajima S; Suzuki T; Mimura M; Uchida H
J Clin Pharmacol; 2016 Sep; 56(9):1111-9. PubMed ID: 26813241
[TBL] [Abstract][Full Text] [Related]
29. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.
Hajak G; Rodenbeck A; Voderholzer U; Riemann D; Cohrs S; Hohagen F; Berger M; Rüther E
J Clin Psychiatry; 2001 Jun; 62(6):453-63. PubMed ID: 11465523
[TBL] [Abstract][Full Text] [Related]
30. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
31. Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression.
McCall WV; Blocker JN; D'Agostino R; Kimball J; Boggs N; Lasater B; Haskett R; Krystal A; McDonald WM; Rosenquist PB
J Clin Sleep Med; 2010 Aug; 6(4):322-9. PubMed ID: 20726279
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression.
Stahl S; Zivkov M; Reimitz PE; Panagides J; Hoff W
Acta Psychiatr Scand Suppl; 1997; 391():22-30. PubMed ID: 9265948
[TBL] [Abstract][Full Text] [Related]
33. Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.
Radhakishun FS; van den Bos J; van der Heijden BC; Roes KC; O'Hanlon JF
J Clin Psychopharmacol; 2000 Oct; 20(5):531-7. PubMed ID: 11001237
[TBL] [Abstract][Full Text] [Related]
34. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
Dolev Z
Arch Womens Ment Health; 2011 Jun; 14(3):269-73. PubMed ID: 21311927
[TBL] [Abstract][Full Text] [Related]
35. The effects of mirtazapine on sleep in patients with major depressive disorder.
Dolder CR; Nelson MH; Iler CA
Ann Clin Psychiatry; 2012 Aug; 24(3):215-24. PubMed ID: 22860241
[TBL] [Abstract][Full Text] [Related]
36. Mirtazapine compared with paroxetine in major depression.
Benkert O; Szegedi A; Kohnen R
J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
Krystal A; Fava M; Rubens R; Wessel T; Caron J; Wilson P; Roth T; McCall WV
J Clin Sleep Med; 2007 Feb; 3(1):48-55. PubMed ID: 17557453
[TBL] [Abstract][Full Text] [Related]
38. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
Ladeira RB; Cunha FT; Salgado JV; Teixeira AL; Nicolato R
Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
[No Abstract] [Full Text] [Related]
39. A Phase 2 Randomized Dose-Finding Study With Esmirtazapine in Patients With Primary Insomnia.
Ruwe F; IJzerman-Boon P; Roth T; Zammit G; Ivgy-May N
J Clin Psychopharmacol; 2016 Oct; 36(5):457-64. PubMed ID: 27482970
[TBL] [Abstract][Full Text] [Related]
40. Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
Prospero-Garcia KA; Torres-Ruiz A; Ramirez-Bermudez J; Velazquez-Moctezuma J; Arana-Lechuga Y; Teran-Perez G
J Clin Psychiatry; 2006 Nov; 67(11):1820. PubMed ID: 17196069
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
